Recent Updates
Recently added Catalysts
IONS

Isis Pharmaceuticals to Receive $7.5 Million from Alnylam

Monday, January 13, 2014 1 min read
Key Takeaway: Isis Pharmaceuticals to Receive $7.5 Million from Alnylam

Full Press Release Details

Isis Pharmaceuticals to Receive $7.5 Million from Alnylam.
Tags: IONS Viatris Investor Conferences Healthcare investor conferences healthcare conferences UBS Global Healthcare
Last updated: Jan 13, 2014